Task: Answer the multiple choice question.
Query: Which drug exhibits a 0.488\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a COc1ccc2c(c1)C(=O)CCC2c1ccccc1
b CCOC(=O)N1CCC(n2c(SCC(=O)N3CCCC3)nc3ccccc3c2=O)CC1
Answer: b. CCOC(=O)N1CCC(n2c(SCC(=O)N3CCCC3)nc3ccccc3c2=O)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)N1CCC(n2c(SCC(=O)N3CCCC3)nc3ccccc3c2=O)CC1
CCOC(=O)N1CCC(n2c(SCC(=O)N3CCCC3)nc3ccccc3c2=O)CC1
ethyl 4-[4-oxo-2-(2-oxo-2-pyrrolidin-1-ylethyl)sulfanylquinazolin-3-yl]piperidine-1-carboxylate